![Tao Huang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tao Huang
Directeur/Membre du Conseil chez Hrain Biotechnology Co., Ltd.
Profil
Tao Huang is currently a Member-Supervisory Board at Hrain Biotechnology Co., Ltd.
She completed her undergraduate degree from Guangxi University of Science & Technology in 1993.
Postes actifs de Tao Huang
Sociétés | Poste | Début |
---|---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 18/06/2021 |
Formation de Tao Huang
Guangxi University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |